Influenza Vaccines May Vary in Amount of Allergenic Components
People with egg or gelatin allergies shouldnt assume that just because theyve had a flu shot safely in the past they will be able to again, according to a new study, presented by Amber M. Patterson, MD, from Ohio State University and Nationwide Children's Hospital in Columbus, Ohio, at the American College of Allergy, Asthma and Immunology annual meeting in Phoenix Nov. 11-16, 2010.
Â
Researchers found influenza vaccines (seasonal and H1N1) can contain different amounts of allergenic components, most commonly egg and/or gelatin. These varying amounts of egg and gelatin mean people who are allergic cant assume the flu shot they are getting wont cause a reaction, say researchers.
Â
Allergists suggest that any egg- or gelatin-allergic patient, or anyone with history of severe reaction to any type of influenza vaccine, be tested to the specific vaccine lot number they will be given prior to immunization. It should never be assumed that tolerating one dose of influenza vaccine suggests future tolerance, say the authors.
Â
Egg allergy is the second most common food allergy in children, affecting 1.5-3.2 percent of children. Sixty-eight percent of children outgrow egg allergy by age 16. An allergist can help identify egg allergies and discuss options for flu shots. Since about 70 percent of asthmatics also have allergies, people with asthma should discuss the importance of getting vaccinated with their allergist.
Â
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
